The AGPAT2 Gene Lipodystrophy Generalized Type 1 NGS Genetic DNA Test is a crucial diagnostic tool for identifying genetic predispositions to lipodystrophy. This test focuses on the AGPAT2 gene, which plays a significant role in lipid metabolism.it is essential for individuals experiencing symptoms of metabolic disorders. Our test is conducted using Next-Generation Sequencing (NGS) technology, ensuring high accuracy and reliability. Results typically take 3 to 4 weeks, with home sample collection available across major cities in Kenya.
